Your browser doesn't support javascript.
loading
Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction.
Robinson, Adam C; Marini, Bernard L; Pettit, Kristen M; Perissinotti, Anthony J.
Affiliation
  • Robinson AC; University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
  • Marini BL; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
  • Pettit KM; Division of Hematology/Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, USA.
  • Perissinotti AJ; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
J Oncol Pharm Pract ; 26(1): 200-205, 2020 Jan.
Article in En | MEDLINE | ID: mdl-30760167
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Chemical and Drug Induced Liver Injury / Antineoplastic Agents Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Chemical and Drug Induced Liver Injury / Antineoplastic Agents Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2020 Type: Article Affiliation country: United States